For the quarter ended September 2023, Invitae (NVTA) reported revenue of $121.24 million, down 9.2% over the same period last year. EPS came in at -$0.10, compared to -$0.42 in the year-ago quarter.

In the latest trading session, Invitae (NVTA) closed at $29.95, marking a +1.66% move from the previous day. This change outpaced the S&P 500's 0.74% gain on the day. Coming into today, shares of the ...

Invitae (NVTA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one ...

Hi, everyone. Good afternoon. Thanks for joining us here. If you don't know me, my name is Andrew Brackmann, I cover diagnostics for William Blair. This afternoon, we have Invitae joining us. We have ...

Invitae is facing two main challenges - assembling a coherent business model from dozens of acquisitions and avoiding a cash crunch looming in 2024/2025. The company has taken decisive action to ...

Invitae (NYSE:NVTA) layoffs are coming to the genetics company after announcing plans to divest assets of health tech platform Ciitizen. Alongside this announcement, the company said it will be taking ...